1-(2,3-二氢苯并[B][1,4]二氧杂环己烯-6-基)丙-1-酮 | 20632-12-6

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 苯并二恶烷
• 中文名称: 1-(2,3-二氢苯并[B][1,4]二氧杂环己烯-6-基)丙-1-酮
• 英文名称: 6-propionyl-1,4-benzodioxane
• 英文别名: 1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)propan-1-one；3',4'-(ethylenedioxy)propiophenone；1-(2,3-Dihydro-1,4-benzodioxin-6-yl)propan-1-one
• CAS: 20632-12-6
• 化学式: C₁₁H₁₂O₃
• mdl: MFCD00859367
• 分子量: 192.214
• InChiKey: HRZXLSBBORQKLM-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.363
• 拓扑面积：
  35.5
• 氢给体数：
  0
• 氢受体数：
  3

安全信息

• 储存条件：
  室温下保存于惰性气体中

反应信息

• 作为反应物：
  描述：

  1-(2,3-二氢苯并[B][1,4]二氧杂环己烯-6-基)丙-1-酮 在 溴 作用下， 以 乙醚 为溶剂， 生成 1-(3,4-ethylenedioxyphenyl)-2-bromopropanone
  参考文献：
  名称：

  Ethylenedioxy homologs of N -methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA) and its corresponding cathinone analog methylenedioxymethcathinone: Interactions with transporters for serotonin, dopamine, and norepinephrine

  摘要：

  N-Methyl-(3,4-methylenedioxyphenyl)-2-aminopropane (MDMA; 'Ecstasy'; 1) and its beta-keto analog methylone (MDMC; 2) are popular drugs of abuse. Little is known about their ring-expanded ethylenedioxy homologs. Here, we prepared N-methyl-(3,4-ethylenedioxyphenyl)-2-aminopropane (EDMA; 3), both of its optical isomers, and beta-keto EDMA (i.e., EDMC; 4) to examine their effects at transporters for serotonin (SERT), dopamine (DAT), and norepinephrine (NET). In general, ring-expansion of the methylenedioxy group led to a several-fold reduction in potency at all three transporters. With respect to EDMA (3), S(+)3 was 6-fold, 50-fold, and 8-fold more potent than its R(-) enantiomer at SERT, DAT, and NET, respectively. Overall, in the absence of a beta-carbonyl group, the ethylenedioxy (i.e., 1,4-dioxane) substituent seems better accommodated at SERT than at DAT and NET. (C) 2015 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2015.07.035
• 作为产物：
  描述：

  1,4-苯并二恶烷 、 丙酸酐 在 aluminum (III) chloride 、 碳酸二甲酯 作用下， 生成 1-(2,3-二氢苯并[B][1,4]二氧杂环己烯-6-基)丙-1-酮
  参考文献：
  名称：

  1,1-双三氟甲基甲醇衍生物作为肝X受体β选择性激动剂的设计、合成和药理学

  摘要：

  发现了一系列作为肝 X 受体 (LXR) β-选择性激动剂的新型 1,3-双三氟甲基甲醇衍生物。结构-活性关系研究导致分子62的鉴定，它比 T0901317 和 GW3965 对 LXRβ更有效 ( E max ) 和选择性。此外，在 Bio F 1中， 62降低了 LDL-C 而没有提高血浆 TG 水平，并显着抑制了主动脉弓中的脂质积聚区域B 仓鼠喂食高脂肪和高胆固醇的饮食。我们证明了我们的 LXRβ 激动剂可能用作降血脂和抗动脉粥样硬化剂。在这份手稿中，我们报告了 1,3-双三氟甲基甲醇衍生物的设计、合成和药理学。

  DOI：

  10.1016/j.bmcl.2015.04.080

文献信息

• Cu-Catalyzed [3 + 3] Annulation for the Synthesis of Pyrimidines via β-C(sp³)–H Functionalization of Saturated Ketones
  作者：Jun-Long Zhan、Meng-Wei Wu、Fei Chen、Bing Han

  DOI：10.1021/acs.joc.6b02181

  日期：2016.12.2

  A novel, efficient, and facile approach for the synthesis of structurally important pyrimidines has been successfully developed by Cu-catalyzed and 4-HO-TEMPO-mediated [3 + 3] annulation of commercially available amidines with saturated ketones. This method provides a new protocol for the synthesis of pyrimidines by a cascade reaction of oxidative dehydrogenation/annulation/oxidative aromatization

  通过Cu催化和4-HO-TEMPO介导的[3 + 3]环戊烷与饱和酮的合成，已成功开发出一种新颖，高效且简便的方法，用于合成结构上重要的嘧啶。该方法为氧化嘧啶脱氢/环化/氧化芳构化的级联反应提供了一个新的协议，该反应通过饱和酮的直接β-C（sp 3）-H官能化，然后与am进行环氧化而进行。
• [EN] AN EFFICIENT PROCESS FOR PREPARATION OF ACYL DERIVATIVES OF ALKYLENEDIOXYBENZENES<br/>[FR] PROCÉDÉ EFFICACE POUR LA PRÉPARATION DE DÉRIVÉS ACYLE D'ALKYLÈNEDIOXYBENZÈNES
  申请人：ANTHEA AROMATICS PRIVATE LTD

  公开号：WO2021161083A1

  公开（公告）日：2021-08-19

  The present disclosure provides a process of preparation of compounds of Formula I comprising the step of : reacting an alkylenedioxybenzene compound of Formula II with an acyl halide of Formula III in presence of a solvent, wherein the step of reacting the alkylenedioxybenzene compound of Formula II with the acyl halide of Formula III is effected in presence of an amphoteric oxide and a Lewis acid so as to immediately quench the compound of formula H-X, formed during the course of the reaction, to substantially eliminate degradation of the compound of any of Formula I and II. The present disclosure also provides for process(es) for preparation of compound of Formula IVa, IVb and IVc.

  本公开提供了一种制备I式化合物的过程，包括以下步骤：在溶剂存在下，将II式烷二氧基苯化合物与III式酰卤反应，其中将II式烷二氧基苯化合物与III式酰卤反应的步骤在存在两性氧化物和路易斯酸的情况下进行，以立即淬灭在反应过程中形成的H-X式化合物，从而实质性地消除任何I式和II式化合物的降解。本公开还提供了制备IVa、IVb和IVc式化合物的过程。
• Novel synthesis of divergent aryl imidazoles from ketones involving copper-catalyzed α-amination and oxidative C–C bond cleavage
  作者：Jiangkun Huang、Lan Luo、Naiguo Xing、Linghui Gu、Chen Li、Qiao Han、Shilong Zheng、Ling He

  DOI：10.1039/d0ra01408g

  日期：——

  A one-pot synthesis, initiated by a copper salt with inorganic (NH4)2CO3 as the nitrogen source, forms divergent aryl imidazole derivatives from ketones via α-amination and oxidative C–C bond cleavage reactions. The approach provides a simple and rapid synthesis of imidazole derivatives and has certain versatility.

  以铜盐和无机(NH 4 ) 2 CO 3作为氮源引发的一锅合成，通过α-胺化和氧化C-C键断裂反应从酮形成不同的芳基咪唑衍生物。该方法提供了一种简单、快速的咪唑衍生物合成方法，具有一定的通用性。
• CARBINOL DERIVATIVES HAVING CYCLIC LINKER
  申请人：Yamaguchi Yuki

  公开号：US20100048610A1

  公开（公告）日：2010-02-25

  [Object] To provide a novel LXRβ agonist that is useful as a preventative and/or therapeutic agent for atherosclerosis; arteriosclerosis such as those resulting from diabetes; dyslipidemia; hypercholesterolemia; lipid-related diseases; inflammatory diseases that are caused by inflammatory cytokines; skin diseases such as allergic skin diseases; diabetes; or Alzheimer's disease. [Solving Means] A carbinol compound represented by the following general formula (I) or salt thereof, or their solvate.

  提供一种新型的LXRβ激动剂，可用作预防和/或治疗动脉粥样硬化；动脉硬化，如糖尿病引起的动脉硬化；血脂异常；高胆固醇血症；与脂质相关的疾病；由炎性细胞因子引起的炎症性疾病；过敏性皮肤病；糖尿病；或阿尔茨海默病的治疗剂。【解决手段】以下一般式（I）所表示的羟甲基化合物或其盐，或其溶剂化合物。
• Direct synthesis of ethers from aldehydes and ketones. One-pot reductive etherification of benzaldehydes, alkyl aryl ketones, and benzophenones
  作者：S. S. Mochalov、A. N. Fedotov、E. V. Trofimova、N. S. Zefirov

  DOI：10.1134/s1070428016040047

  日期：2016.4

  Benzyl alcohols formed by the reduction of benzaldehydes, alkyl aryl ketones, and benzophenones with sodium tetrahydridoborate in alcohols undergo in situ etherification with the solvent in the presence of a catalytic amount of HCl. Thus the process may be regarded as one-pot transformation of carbonyl compounds into the corresponding benzyl ethers. The yields of ethers depend on the substituent nature

  通过在醇中催化量的四氢硼酸钠将苯甲醛，烷基芳基酮和二苯甲酮还原而形成的苄醇在催化量的HCl的存在下与溶剂进行原位醚化。因此，该方法可以被认为是羰基化合物一锅转化为相应的苄基醚。醚的产率取决于初始羰基化合物的芳族片段中的取代基性质以及用作还原介质的醇。